Pharmaceutical News

RSS

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

GE Healthcare today announced that it has submitted an application to amend its European Marketing Authorisation that will allow the company to manufacture Optison 0.19 mg/ml dispersion for injection within its own facility.

30 Mar 2013

FDA approves Teva's Quartette tablets for prevention of pregnancy

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy.

30 Mar 2013

Medivir seeks FDA approval for simeprevir

Medivir AB today announced that a new drug application has been filed with the U.S. Food and Drug Administration seeking approval for simeprevir.

30 Mar 2013

Parents, officials in Pakistan working to bring polio vaccine to areas under militant control

"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.

30 Mar 2013

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Methadone treatment for opioid dependence remains widely unavailable behind bars in the United States, and many inmates are forced to discontinue this evidence-based therapy, which lessens painful withdrawal symptoms.

30 Mar 2013

South Africa to host third global forum on TB vaccines

"This week more than 250 scientists, researchers, and tuberculosis (TB) advocates from all over the world will gather in Cape Town, South Africa, at the Third Global Forum on TB Vaccines to share findings and look to the future of TB vaccine research and development,"

29 Mar 2013

Study: Diabetes drug slows down ageing process by mimicking the effects of dieting

A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.

29 Mar 2013

New evidence shows older adults with dementia can be taken off antipsychotic medications

Most older adults with dementia can successfully be taken off antipsychotic medications, which have negative side effects and increase the risk of death, finds a new evidence review from The Cochrane Library.

29 Mar 2013

Drug costs and pricing issues touch hospitals, independent pharmacies

NPR reports on how one hospital made what is termed an "unusual decision" -- it chose to not stock a new drug because it was very costly.

29 Mar 2013

Study explores a better alternative for treating bipolar disorder

Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body - with an eye to developing a safer alternative.

28 Mar 2013

TSRI scientists receive innovative grant to help people break nicotine addiction

As part of an unprecedented national effort to develop new drugs to treat neurological disorders, scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded an innovative grant from the National Institute of Neurological Disorders and Stroke to help people break their addiction to nicotine.

28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.

28 Mar 2013

TSRI scientists awarded innovative grant to develop anti-smoking drug candidates

As part of an unprecedented national effort to develop new drugs to treat neurological disorders, scientists from the Florida campus of The Scripps Research Institute have been awarded an innovative grant from the National Institute of Neurological Disorders and Stroke to help people break their addiction to nicotine.

28 Mar 2013

Smokers trying to quit will have better experience with varenicline, study finds

Smokers have a higher probability of quitting smoking and a better overall cessation experience when taking varenicline compared to bupropion and to placebo - unmedicated assisted smoking cessation -according to a study published in the journal JAMA Psychiatry.

28 Mar 2013

Tecfidera gets FDA approval for adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.

28 Mar 2013

New study associates commonly used diabetes drugs with pancreatic cancer risk

ndividuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine tumors, according to a new study by researchers from UCLA and the University of Florida.

28 Mar 2013

Patients taking antihistamines to suppress stomach acid are at greater risk of C. diff infection

Patients receiving antihistamines to suppress stomach acid are at greater risk of infection from Clostridium difficile, or C. diff, a common cause of diarrhea, particularly in health care settings, Mayo Clinic researchers have found.

28 Mar 2013

Chelation therapy with drug disodium EDTA reduces risk of heart attack

Although chelation therapy with the drug disodium EDTA has been used for many years with limited evidence of efficacy for the treatment of coronary disease, a randomized trial that included patients with a prior heart attack found that use of a chelation regimen modestly reduced the risk of a composite of adverse cardiovascular outcomes.

27 Mar 2013

Pharmaceutical News

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

FDA approves Teva's Quartette tablets for prevention of pregnancy

Medivir seeks FDA approval for simeprevir

Parents, officials in Pakistan working to bring polio vaccine to areas under militant control

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

South Africa to host third global forum on TB vaccines

Study: Diabetes drug slows down ageing process by mimicking the effects of dieting

New evidence shows older adults with dementia can be taken off antipsychotic medications

Drug costs and pricing issues touch hospitals, independent pharmacies

Study explores a better alternative for treating bipolar disorder

TSRI scientists receive innovative grant to help people break nicotine addiction

First Edition: March 28, 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

TSRI scientists awarded innovative grant to develop anti-smoking drug candidates

Smokers trying to quit will have better experience with varenicline, study finds

Tecfidera gets FDA approval for adults with relapsing forms of MS

New study associates commonly used diabetes drugs with pancreatic cancer risk

Patients taking antihistamines to suppress stomach acid are at greater risk of C. diff infection

Chelation therapy with drug disodium EDTA reduces risk of heart attack

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News